| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139493 delivery of various cargo moieties into cells; more amenable than peptide "protein transduction domains" due to their ease of preparation and in vivo stability by virtue of their resistance to cellular enzymes that degrade peptides |
| 06/12/2008 | US20080139467 Method and Products For the Selective Degradation of Proteins |
| 06/12/2008 | US20080139453 Comprising an emulsifying crosslinked siloxane elastomer, a hydrophobically modified polymeric emulsifier, a solvent for the emulsifying crosslinked siloxane elastomer and water; for moisturizing, protecting and/or treating the skin and/or keratinous fibers; sunscreen |
| 06/12/2008 | US20080139392 Linker-Based Lecithin Microemulsion Delivery Vehicles |
| 06/12/2008 | US20080138899 Destroying cell expressing polypeptide of given sequence by contacting with cytotoxic immunoconjugate; ricin, doxorubicin; treatment and detection of prostate cancer metastasis |
| 06/12/2008 | US20080138849 Use of mdck cell line to predict corneal penetration of drugs |
| 06/12/2008 | US20080138442 Personal care method free of zinc pyrithione; basic zinc carbonate hydroxide, zinc copper carbonate, copper zinc carbonate hydroxide, phyllosilicate; anionic surfactant; skin, not scalp; treating microbial and fungal infections |
| 06/12/2008 | US20080138437 Reduce toxicity while maintaining efficacy; mix with particulate hydroxyapatite as an auxiliary agent; alkylating agent, antimetabolite, an antitumor antibiotic, plant preparation, hormone preparation, immunotherapeutic agent, cisplatin; injection, infusion, oral administration |
| 06/12/2008 | US20080138430 Gold sulfide core, gold shell; interpenetrating polymer network of polyacrylic acid, polyacrylamide; irradiate particles with Nd Yag laser to effect temperature induced swelling; near infrared light passes easily and harmlessly through the body |
| 06/12/2008 | US20080138428 Fast-Disintegrating Microporous Binders |
| 06/12/2008 | US20080138419 Method for preparing an orally administrable formulation for controlled release |
| 06/12/2008 | US20080138418 Drug delivery polymers from n-butyl cyanoactylate and 2-octyl cyanoacrylate |
| 06/12/2008 | US20080138402 Highly inhibited starch fillers for films and capsules |
| 06/12/2008 | US20080138401 Delivery vehicle comprising a modified MscL protein channel |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138377 Vasodilator Eluting Luminal Stent Devices With A Specific Polyphosphazene Coating and Methods for Their Manufacture and Use |
| 06/12/2008 | US20080138338 Polypeptide variants |
| 06/12/2008 | US20080138322 Pretreating with lipophilic substituted saccharide |
| 06/12/2008 | US20080138280 Composition and Methods For Inhibiting Cell Survival |
| 06/12/2008 | US20080138277 Drug delivery of therapeutic agent and carrier comprising targeting moiety that interacts with a target molecule such as chemokines, interferons, interleukins, osteoponting, chaperone proteins, receptors, and cellular adhesion molecules present in atherosclerotic lesions in blood vessels; diagnosis |
| 06/12/2008 | US20080138275 Hybridoma cell line G250 and its use for producing monoclonal antibodies |
| 06/12/2008 | DE102006057904A1 Herstellung von Cellulose-Nanopartikeln Preparation of cellulose nanoparticles |
| 06/12/2008 | CA2707233A1 Organic-inorganic hybrid particles containing contrast agent |
| 06/12/2008 | CA2699837A1 Variant target binding agents and uses thereof |
| 06/12/2008 | CA2671975A1 Film-coated preparation having improved stability |
| 06/12/2008 | CA2671737A1 Prodrugs and methods of making and using the same |
| 06/12/2008 | CA2671636A1 Pharmaceutical composition for external application and adhesive skin patch |
| 06/12/2008 | CA2671571A1 High protein concentration formulations containing mannitol |
| 06/12/2008 | CA2671461A1 Vesicles of self-assembling block copolymers and methods for making and using the same |
| 06/12/2008 | CA2671447A1 Amphiphilic entity nanoparticles |
| 06/12/2008 | CA2670746A1 Intraocular drug delivery systems |
| 06/12/2008 | CA2669871A1 Anti-microorganism terpenic composition |
| 06/12/2008 | CA2643826A1 Compositions and methods for transport of molecules with enhanced release properties across biological barriers |
| 06/11/2008 | EP1930436A1 Vector for delivering target substance into nucleus or cell |
| 06/11/2008 | EP1930406A1 Brain-migrating cell and use thereof |
| 06/11/2008 | EP1930343A1 Method for preparation of reduced keratin, reduced cuticle protein or mixture thereof |
| 06/11/2008 | EP1930337A1 Water-soluble metal alcoholate derivative, process for production of the derivative, and solid gelatinous agent for external application comprising the derivative |
| 06/11/2008 | EP1930030A1 Pulse preparation having improved disintegration properties in vivo |
| 06/11/2008 | EP1930029A1 Particle for medical use and process for producing the same |
| 06/11/2008 | EP1930028A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 06/11/2008 | EP1930027A2 A composition of sodium channel blocking compound |
| 06/11/2008 | EP1930024A2 G-CSF solution formulations having long-term stability |
| 06/11/2008 | EP1930012A1 Cellooligosaccharide-containing composition |
| 06/11/2008 | EP1930008A1 Sable composition of benazepril hydrochloride |
| 06/11/2008 | EP1930006A1 Method for production of quinolone-containing lyophilized preparation |
| 06/11/2008 | EP1930005A1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 06/11/2008 | EP1929860A1 Transgenic avian which has foreign gene containing sequence encoding feline-derived protein and method for production thereof |
| 06/11/2008 | EP1929297A2 Biomarkers for multiple sclerosis and methods of use thereof |
| 06/11/2008 | EP1928910A1 A method for the mass production of immunoglobulin fc region deleted initial methionine residues |
| 06/11/2008 | EP1928906A2 Liquid formulations of pegylated growth hormone |
| 06/11/2008 | EP1928594A2 Method for production of single- and multi-layer microcapsules |
| 06/11/2008 | EP1928508A1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents |
| 06/11/2008 | EP1928503A2 Process for preparing maytansinoid antibody conjugates |
| 06/11/2008 | EP1928502A2 Modified fc molecules |
| 06/11/2008 | EP1928501A2 Kit for parenteral administration of medicaments |
| 06/11/2008 | EP1928469A1 Fulvestrant formulation |
| 06/11/2008 | EP1928449A1 Acetylcysteine composition and uses therefor |
| 06/11/2008 | EP1928441A2 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation |
| 06/11/2008 | EP1928439A2 Methods for treatment and prevention of otitis media using chemical penetration enhancers to facilitate transmembrane drug delivery into the middle ear |
| 06/11/2008 | EP1928435A2 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 06/11/2008 | EP1928426A2 Method for stabilising pharmaceutical administration forms that contain micro-organisms |
| 06/11/2008 | EP1928415A2 Topical delivery with a carrier fluid |
| 06/11/2008 | EP1928411A2 Use of octenidine dihydrochloride in semisolid preparations |
| 06/11/2008 | EP1928408A1 Orodispersible tablets of bitter active principles |
| 06/11/2008 | EP1928406A2 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 06/11/2008 | EP1928313A1 Self-assembled biodegradable polymersomes |
| 06/11/2008 | EP1928235A2 Composition and method for use in cartilage affecting conditions |
| 06/11/2008 | EP1758612B1 Composition comprising intercalated functional-active organic compounds |
| 06/11/2008 | EP1729778B1 Pharmaceutical preparation containing drospirenone for application to the skin |
| 06/11/2008 | EP1517709B1 Transdermal drug delivery system |
| 06/11/2008 | EP1490103B1 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthama(obstructive lung disease) |
| 06/11/2008 | EP1453598B1 Method for preparing a multiple water/oil/water emulsion |
| 06/11/2008 | EP1451184B1 Dimeric compounds and their use as anti-viral agents |
| 06/11/2008 | EP1438032B1 Production of starch-gel-based shaped bodies |
| 06/11/2008 | EP1392846B1 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 06/11/2008 | EP1197227B9 Method of the administration of drugs having binding affinity with plasma protein and preparation to be used in the method |
| 06/11/2008 | CN101198693A Variant forms of urate oxidase and use thereof |
| 06/11/2008 | CN101198357A Human granulocyte-colony stimulating factor isoforms |
| 06/11/2008 | CN101198356A External preparation, method of applying external preparation, iontophoresis device, and percutaneous patch |
| 06/11/2008 | CN101198342A Composition for inducing sleep comprising essential oils as active ingredients, a percutaneous pharmaceutical agent comprising thereof, and a process for producing thereof |
| 06/11/2008 | CN101198331A Solubilization preparation |
| 06/11/2008 | CN101198319A Granular preparation containing biguanide compound |
| 06/11/2008 | CN101198316A Nanoparticulate bisphosphonate compositions |
| 06/11/2008 | CN101198313A Pharmaceutical formulations comprising a long-acting beta2-agonist for administration by nebulisation |
| 06/11/2008 | CN101195649A Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 06/11/2008 | CN101195032A Method for preparing coupled article of polyasparamide derivant and adriablastina, and uses thereof |
| 06/11/2008 | CN101195031A Gluconic acid modified chitosan nucleophilic NO donator and synthesizing method thereof |
| 06/11/2008 | CN101195030A Method for preparing ternary block polymer of polycaprolactone-polyglycol-polycaprolactone medicine-loading nanoparticle |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN101195027A Application of lysostaphin in preparing medicament for treating osteomyelitis |
| 06/11/2008 | CN101195025A Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (tb4) analogues, isoforms and other derivatives |
| 06/11/2008 | CN101194983A Dropping pills for treating sudden deafness and method for preparing the same |
| 06/11/2008 | CN101194923A Novel medicament for treating systematic lupus erythematosus |
| 06/11/2008 | CN101194919A Hippophae rhamnoides seed oil fatty milk injection and technique of preparing the same |
| 06/11/2008 | CN101194910A Dropping pills containing acegastrodine and method for preparing the same |
| 06/11/2008 | CN101194909A Dropping pills containing gastrodine and method for preparing the same |
| 06/11/2008 | CN101194908A Dropping pills containing lorazepam and method for preparing the same |
| 06/11/2008 | CN101194907A Dropping pills containing noscapine and method for preparing the same |
| 06/11/2008 | CN101194906A Dropping pills for treating hypersensitivity disease and method for preparing the same |